Mithra Pharmaceuticals S.A.
Biotech firm developing pharma for women's health: contraception, fertility, and menopause.
MITRA | BR
Overview
Corporate Details
- ISIN(s):
- BE0974283153 (+1 more)
- LEI:
- 5493002FDD273HTEKK14
- Country:
- Belgium
- Address:
- Rue Saint-Georges 5, 4000 Liège
- Website:
- https://www.mithra.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Mithra Pharmaceuticals S.A. is a biotechnology company dedicated to women's health. The company specializes in the development, manufacturing, and commercialization of proprietary and over-the-counter pharmaceutical products. Its core focus areas include contraception, fertility, and menopause. Mithra's mission is to transform the women's health sector by providing innovative new choices that aim to improve the overall quality of life for women.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-06-11 10:00 |
M&A Activity
2024-06-11_Mithra_Press-Release_Mithra sells to GR_EN-FS (003) (002)-PDF.pdf
|
English | 179.8 KB | ||
| 2024-06-11 10:00 |
M&A Activity
2024-06-11_Mithra_Press-Release_Mithra sells to GR_FR-FS-PDF.pdf
|
French | 126.7 KB | ||
| 2024-06-10 19:15 |
Legal Proceedings Report
2024-06-10_Mithra_Press-Release_Mithra files for bankruptcy AND sells to GR_EN.…
|
English | 181.9 KB | ||
| 2024-06-10 19:15 |
Legal Proceedings Report
2024-06-10_Mithra_Press-Release_Mithra files for bankruptcy AND sells to GR_FR.…
|
French | 128.7 KB | ||
| 2024-06-04 08:00 |
Legal Proceedings Report
2024-0~1.PDF
|
English | 153.0 KB | ||
| 2024-06-04 08:00 |
Legal Proceedings Report
2024-0~2.PDF
|
French | 158.7 KB | ||
| 2024-05-28 15:00 |
Pre-Annual General Meeting Information
2024-05-28_Mithra_Press-release_Mithra postpones its annual general meeting_EN.…
|
English | 139.6 KB | ||
| 2024-05-28 15:00 |
Pre-Annual General Meeting Information
2024-05-28_Mithra_Press-release_Mithra postpones its annual general meeting_FR.…
|
French | 143.3 KB | ||
| 2024-05-10 16:30 |
Regulatory News Service
2024-05-10_Mithra_Press-release_Additional patent protection NEXSTELLIS_EN.pdf
|
English | 124.3 KB | ||
| 2024-05-10 16:30 |
Regulatory News Service
2024-05-10_Mithra_Press-release_Additional patent protection NEXSTELLIS_FR.pdf
|
French | 126.5 KB | ||
| 2024-05-03 17:30 |
M&A Activity
2024-05-03_Mithra_Press-release_Mithra Announces Exclusive Negotiations and Fun…
|
English | 142.7 KB | ||
| 2024-05-03 17:30 |
Capital/Financing Update
2024-05-03_Mithra_Press-release_Mithra Announces Exclusive Negotiations and Fun…
|
French | 145.9 KB | ||
| 2024-04-30 10:30 |
Proxy Solicitation & Information Statement
2024-04-30_MITHRA_VOTING-BY-MAIL-FORM_AGO-MAY-2024_EN.pdf
|
English | 141.0 KB | ||
| 2024-04-30 10:30 |
Pre-Annual General Meeting Information
2024-04-30_MITHRA_AGENDA_AGO-MAY-2024_FR.pdf
|
French | 143.1 KB | ||
| 2024-04-30 10:30 |
Proxy Solicitation & Information Statement
2024-04-30_MITHRA_PROXY-FORM_AGO-MAY-2024_EN.pdf
|
English | 145.2 KB |
Automate Your Workflow. Get a real-time feed of all Mithra Pharmaceuticals S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Mithra Pharmaceuticals S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-01-17 | NOSHAQ SA | Board | Other | 172,574 | 617,814.92 EUR |
| 2022-11-17 | NOSHAQ SA | Board | Other | 172,574 | 1,052,701.40 EUR |
| 2022-07-18 | NOSHAQ SA | Board | Other | 156,250 | 1,006,250.00 EUR |
| 2022-05-13 | NOSHAQ SA | Board | Other | 156,250 | 1,239,062.50 EUR |
| 2022-04-13 | Gordenne Valérie | Other | Sell | 8,500 | 87,380.00 EUR |
| 2022-03-29 | Fornieri Francesco | Board | Sell | 100,000 | 1,312,000.00 EUR |
| 2022-03-25 | Fornieri Francesco | Board | Sell | 35,893 | 486,530.57 EUR |
| 2022-03-24 | Fornieri Francesco | Board | Sell | 15,657 | 219,536.19 EUR |
| 2022-03-24 | Fornieri Francesco | Board | Sell | 2,818 | 39,452.00 EUR |
| 2022-03-23 | Fornieri Francesco | Board | Sell | 12,525 | 178,230.75 EUR |
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
